U.S. flag

An official website of the United States government

GTR Home > Tests > Lysosomal Disorders NGS Panel

Interpretation

Sample Negative Report

Help

Not provided

Sample Positive Report

Help

Not provided

Variants Of Unknown Significance (VUS) Policy And Interpretation

What is the protocol for interpreting a variation as a VUS? Help
Not provided

Research

Is research allowed on the sample after clinical testing is complete?Help
Not provided

Practice guidelines

  • NICE, 2023
    UK NICE Guidance, Clinical Guideline CG181, Cardiovascular disease: risk assessment and reduction, including lipid modification, 2023
  • NICE, 2022
    UK NICE Guideline NG18, Diabetes (type 1 and type 2) in children and young people: diagnosis and management
  • NICE, 2022
    UK NICE Guideline NG28, Type 2 diabetes in adults: management, 2022
  • NICE, 2022
    UK NICE Guideline NG136, Hypertension in adults: diagnosis and management, 2022
  • NICE, 2020
    UK NICE Guideline NG3, Diabetes in pregnancy: management from preconception to the postnatal period
  • NICE, 2019
    UK NICE Guideline NG19, Diabetic foot problems: prevention and management, 2019

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.